follow_the_money

follow_the_money

The chart above is based off of pure technicals. This is not investing advise, just my opinion on theoretical Technical analysis with this ticker using Elliot wave theory and Fibonacci ratios along with my own pattern/ trading secrets. See link below for interview our company did with Conatis pharmaceuticals (Nasdaq: CNAT) Feel free to ask questions on ANY...

follow_the_money

daily looks like it may have found support and trend indicators sh0w positive (in upward trend) check indicators in AM may be buy give or take few cents- ong run doesnt matter right?

follow_the_money

cup and handle?

follow_the_money

do own DD on kgkg- recent deal with anheisuer busch and their lead distributer kentucky...bigest deal to date- i expect to see big $ to inflow soon as chart infers, is in an "oversold" territory.

follow_the_money

The beginning of a new age w novelty therapies in Biotech sector (i.e. gene editing, gene therapy, ERT, Pi3K inhibitors, FAK inhibitors, heart disease, diabetes, mental health, medical equipment, cannabis, etc..) The Bio technology sector will see a bunch of M&A in coming years as big pharma merge to take market share in different parts of the industry, novel...

follow_the_money

chart looks very interesting, looks like its formed a cup/handle formation/ could see leg 5 moving this up to around 2.60/75 level where next resistance is

follow_the_money

Today VSTM made hammer after testing ~50% retracement on the daily- Elliot wave theory states that the completion of leg 1 (12345) will have between ~50-61.8% retracement from hi's, which comes out to being leg #2 on the daily chart (this is the ABC corrective wave shown in 15 min chart). The red arrow points to where e-Wave theory projects next big level of...

follow_the_money

looks to be finishing ABC on 15 minute- check for daily chart (pt 2)

follow_the_money

It broke over descending top @ 22.50 with 21.50 acting as support.. seeing room to 25+

follow_the_money

if your looking- you probably know axon fundamentals, police body cams/ tazers ~90 mill recurring revs, but ending patent litigation with DGLY (kind of acting as axon VIX) soon as well as newly 50$ million accordian loan with over 100 PE multiple- needs a BUZZ CUT not just a trim. im seeing about 20% move to downside on this easy. this is my hypothesis on where...

follow_the_money

As many know, AAXN has a very high PE ratio, high operating expenses, litigation w DGLY patent lawsuit, and newly added to their list this week was additional $50 million accordion loan (debt) which can go as high as $100 million. Why did they add debt with all the turmoil with the FED raising rates recently? I am speculating an announcement that AAXN buys either...